None listed
Conditions
Brief summary
Hypoglycaemia is the commonest metabolic condition of the newborn. It affects up to 15% of babies, and the incidence is increasing as risk factors such as maternal diabetes and preterm birth are becoming more common. Neonatal hypoglycaemia frequently leads to neonatal intensive care unit (NICU) admission and may cause long-term brain damage. There currently are no evidence-based strategies to prevent hypoglycaemia and its adverse consequences. The purpose of this trial is to determine whether prophylactic dextrose gel prevents admission to NICU.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Babies who are at risk of hypoglycaemia, defined as satisfying AT LEAST ONE of the following: 1. Infants of diabetic mothers (any type of diabetes) 2. Preterm (< 37 weeks' gestation) 3. Small (< 2.5kg or < 10th centile on population or customised birthweight chart) 4. Large (> 4.5kg or > 90th centile on population or customised birthweight chart) AND satisfy ALL of the following: 1. > or = 35+0 weeks' gestation 2. Birthweight > or = 2.2kg 3. < 1 hour old 4. No apparent indication for NICU/SCBU admission at time of randomisation 5. Unlikely to require admission to NICU/SCBU for any other reason e.g. respiratory distress 6. Mother intending to breastfeed
Exclusion criteria
1. Major congenital abnormality 2. Previous formula feed or intravenous fluids 3. Previous diagnosis of hypoglycaemia 4. Admitted to NICU/SCBU 5. Imminent admission to NICU/SCBU